These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 1380438

  • 1. Phosphorylation of the rodent negative acute-phase protein alpha 1-inhibitor-III by the insulin receptor tyrosine kinase.
    Komori K, Robinson KA, Block NE, Roberts RC, Buse MG.
    Endocrinology; 1992 Sep; 131(3):1288-96. PubMed ID: 1380438
    [Abstract] [Full Text] [Related]

  • 2. Insulin-stimulated phosphorylation of a 195K protein from muscle and liver in the presence of poly-L-lysine.
    Komori K, Block NE, Robinson KA, Buse MG.
    Endocrinology; 1989 Sep; 125(3):1438-50. PubMed ID: 2547586
    [Abstract] [Full Text] [Related]

  • 3. Interleukin 6 is a negative regulator of the acute phase alpha 1-inhibitor III gene.
    Abraham LJ, Bradshaw AD, Fletcher RG, Fey GH.
    Mol Biol Med; 1990 Jun; 7(3):261-71. PubMed ID: 1699110
    [Abstract] [Full Text] [Related]

  • 4. Isolation of rat serum alpha 1-microglobulin. Identification of a complex with alpha 1-inhibitor-3, a rat alpha 2-macroglobulin homologue.
    Falkenberg C, Grubb A, Akerström B.
    J Biol Chem; 1990 Sep 25; 265(27):16150-7. PubMed ID: 1697852
    [Abstract] [Full Text] [Related]

  • 5. Characterization and hepatic expression of rat alpha 1-inhibitor III mRNA.
    Aiello LP, Shia MA, Robinson GS, Pilch PF, Farmer SR.
    J Biol Chem; 1988 Mar 15; 263(8):4013-22. PubMed ID: 2450089
    [Abstract] [Full Text] [Related]

  • 6. Changes in tyrosine phosphorylation of insulin receptors and a 170,000 molecular weight nonreceptor protein in vivo in skeletal muscle of streptozotocin-induced diabetic rats: effects of insulin and glucose.
    Giorgino F, Chen JH, Smith RJ.
    Endocrinology; 1992 Mar 15; 130(3):1433-44. PubMed ID: 1531627
    [Abstract] [Full Text] [Related]

  • 7. Proteinase binding and inhibition by the monomeric alpha-macroglobulin rat alpha 1-inhibitor-3.
    Enghild JJ, Salvesen G, Thøgersen IB, Pizzo SV.
    J Biol Chem; 1989 Jul 05; 264(19):11428-35. PubMed ID: 2472396
    [Abstract] [Full Text] [Related]

  • 8. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner.
    Zhang-Sun G, Yang C, Viallet J, Feng G, Bergeron JJ, Posner BI.
    Endocrinology; 1996 Jul 05; 137(7):2649-58. PubMed ID: 8770882
    [Abstract] [Full Text] [Related]

  • 9. Development of brain insulin receptors: structural and functional studies of insulin receptors from whole brain and primary cell cultures.
    Lowe WL, Boyd FT, Clarke DW, Raizada MK, Hart C, LeRoith D.
    Endocrinology; 1986 Jul 05; 119(1):25-35. PubMed ID: 3522210
    [Abstract] [Full Text] [Related]

  • 10. A 180,000 molecular weight glycoprotein substrate of the insulin receptor tyrosine kinase is present in human placenta and in rat liver, muscle, heart and brain plasma membrane preparations.
    Goren HJ, Neufeld E, Boland D.
    Cell Signal; 1990 Jul 05; 2(6):537-55. PubMed ID: 1964389
    [Abstract] [Full Text] [Related]

  • 11. Effects of exercise training on the relationship between insulin binding and insulin-stimulated tyrosine kinase activity in rat skeletal muscle.
    Santos RF, Mondon CE, Reaven GM, Azhar S.
    Metabolism; 1989 Apr 05; 38(4):376-86. PubMed ID: 2542721
    [Abstract] [Full Text] [Related]

  • 12. Effect of calorie restriction on skeletal muscle and liver insulin binding in growing rat.
    Balage M, Grizard J, Manin M.
    Horm Metab Res; 1990 Apr 05; 22(4):207-14. PubMed ID: 2161787
    [Abstract] [Full Text] [Related]

  • 13. Cholesterol-mediated suppression of alpha 1-inhibitor III, a plasma alpha-macroglobulin family protein.
    Gil G, Esser V.
    J Biol Chem; 1991 Oct 25; 266(30):20512-8. PubMed ID: 1718965
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Diabetes-associated impairment of hepatic insulin receptor tyrosine kinase activity: a study of mechanisms.
    Block NE, Komori K, Robinson KA, Dutton SL, Lam CF, Buse MG.
    Endocrinology; 1991 Jan 25; 128(1):312-22. PubMed ID: 1846101
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tissue distribution and subcellular localization of an endogenous substrate (pp 120) for the insulin receptor-associated tyrosine kinase.
    Accili D, Perrotti N, Rees-Jones R, Taylor SI.
    Endocrinology; 1986 Sep 25; 119(3):1274-80. PubMed ID: 3015574
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance of skeletal muscle during pregnancy is not a consequence of intrinsic modifications of insulin receptor binding or kinase activities.
    Camps M, Gumà A, Testar X, Palacín M, Zorzano A.
    Endocrinology; 1990 Nov 25; 127(5):2561-70. PubMed ID: 2171919
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.